Gujarat Inject [GUJINJEC] vs OneSource Specialty [ONESOURCE] Detailed Stock Comparison

Gujarat Inject (Kerala) Ltd.

BSE
Loading...

OneSource Specialty Pharma Inc.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Gujarat Inject (Kerala) Ltd. wins in 8 metrics, OneSource Specialty Pharma Inc. wins in 8 metrics, with 1 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Gujarat Inject (Kerala) Ltd. OneSource Specialty Pharma Inc. Better
P/E Ratio (TTM) 158.27 936.63 Gujarat Inject (Kerala) Ltd.
Price-to-Book Ratio 12.63 3.11 OneSource Specialty Pharma Inc.
Debt-to-Equity Ratio 0.00 21.93 Tie
PEG Ratio -2.01 42.24 OneSource Specialty Pharma Inc.
EV/EBITDA 93.74 40.79 OneSource Specialty Pharma Inc.
Profit Margin (TTM) 2.51% 1.42% Gujarat Inject (Kerala) Ltd.
Operating Margin (TTM) 2.88% -18.02% Gujarat Inject (Kerala) Ltd.
EBITDA Margin (TTM) 2.88% N/A N/A
Return on Equity 10.16% -0.31% Gujarat Inject (Kerala) Ltd.
Return on Assets (TTM) 8.51% -0.24% Gujarat Inject (Kerala) Ltd.
Free Cash Flow (TTM) $-15.46M $-1.96B Gujarat Inject (Kerala) Ltd.
1-Year Return 425.15% -20.38% Gujarat Inject (Kerala) Ltd.
Price-to-Sales Ratio (TTM) 13.82 13.01 OneSource Specialty Pharma Inc.
Enterprise Value $1.18B $195.90B OneSource Specialty Pharma Inc.
EV/Revenue Ratio 11.69 13.80 Gujarat Inject (Kerala) Ltd.
Gross Profit Margin (TTM) 0.14% 67.50% OneSource Specialty Pharma Inc.
Revenue per Share (TTM) $11 $124 OneSource Specialty Pharma Inc.
Earnings per Share (Diluted) $0.60 $1.72 OneSource Specialty Pharma Inc.
Beta (Stock Volatility) -0.90 N/A N/A

Gujarat Inject (Kerala) Ltd. vs OneSource Specialty Pharma Inc. Stock Performance Analysis

Loading Price Chart...

GUJINJEC
ONESOURCE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gujarat Inject (Kerala) Ltd.-1.68%-2.42%13.59%63.41%279.75%225.27%
OneSource Specialty Pharma Inc.0.68%-6.58%-11.52%8.72%0.44%-9.19%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gujarat Inject (Kerala) Ltd.425.15%1,090.00%3,947.62%3,947.62%3,947.62%3,947.62%
OneSource Specialty Pharma Inc.-20.38%-5.70%-5.70%-5.70%-5.70%-5.70%

Performance & Financial Health Analysis: Gujarat Inject (Kerala) Ltd. vs OneSource Specialty Pharma Inc.

MetricGUJINJECONESOURCE
Market Information
Market Cap i₹1.38B₹202.76B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i22,2921,038,625
90 Day Avg. Volume i41,507610,058
Last Close₹117.00₹1,623.40
52 Week Range₹19.01 - ₹125.50₹1,057.00 - ₹2,248.00
% from 52W High-6.77%-27.78%
All-Time High₹125.50 (Jun 09, 2026)₹2,248.00 (Jun 18, 2025)
% from All-Time High-6.77%-27.78%
Growth Metrics
Quarterly Revenue Growth-0.44%-0.26%
Quarterly Earnings Growth-0.82%N/A
Financial Health
Profit Margin (TTM) i0.03%0.01%
Operating Margin (TTM) i0.03%-0.18%
Return on Equity (TTM) i0.10%0.00%
Debt to Equity (MRQ) i0.0021.93
Cash & Liquidity
Book Value per Share (MRQ)₹7.52₹518.08
Cash per Share (MRQ)₹0.18₹14.56
Operating Cash Flow (TTM) i₹-31,076,498₹-2,152,760,000
Levered Free Cash Flow (TTM) i₹10.17M₹-179,710,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Gujarat Inject (Kerala) Ltd. vs OneSource Specialty Pharma Inc.

MetricGUJINJEC (Apr 24, 2026)ONESOURCE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i158.27936.63
Forward P/E iN/A42.24
PEG Ratio i-2.0142.24
Price to Sales (TTM) i13.8213.01
Price to Book (MRQ) i12.633.11
Market Capitalization
Market Capitalization i₹1.38B₹202.76B
Enterprise Value i₹1.18B₹195.90B
Enterprise Value Metrics
Enterprise to Revenue i11.6913.80
Enterprise to EBITDA i93.7440.79
Risk & Other Metrics
Beta i-0.90N/A
Book Value per Share (MRQ) i₹7.52₹518.08

Financial Statements Comparison: Gujarat Inject (Kerala) Ltd. vs OneSource Specialty Pharma Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGUJINJEC (2025)ONESOURCE (2025)
Revenue/Sales i190.46M14.45B
Cost of Goods Sold i177.77M4.35B
COGS % of Revenue i93.3%30.1%
Gross Profit i12.68M10.10B
Gross Margin i6.7%69.9%
Research & Development iN/A20.49M
Operating Income (EBIT) i10.75M1.90B
Operating Margin i5.6%13.2%
EBITDA i12.56M4.71B
EBITDA Margin i6.6%32.6%
Pre-Tax Income i12.54M-670.66M
Pre-Tax Income % of Revenue i6.6%-4.6%
Income Tax i2.37M-497.85M
Income Tax % of Revenue i1.2%-3.4%
Net Income (Profit) i10.17M-179.71M
Profit Margin i5.3%-1.2%

Balance Sheet & Liquidity Metrics

MetricGUJINJEC (2025)ONESOURCE (2025)
Cash & Equivalents i262,7851.56B
Total Current Assets i99.75M10.86B
Total Current Assets % of Revenue i52.4%75.2%
Total Current Liabilities i19.38M11.14B
Total Current Liabilities % of Revenue i10.2%77.1%
Long-Term Debt i03.83B
Long-Term Debt % of Revenue i0.0%26.5%
Total Shareholders Equity i100.12M58.81B
Retained Earnings iN/A-18.43B
Retained Earnings % of Revenue i0.0%-127.6%
Property, Plant & Equipment iN/A8.97B

Cash Flow Statement Comparison

MetricGUJINJEC (2025)ONESOURCE (2025)
Operating Cash Flow i-31.08M-2.15B
Operating Cash Flow % of Revenue i-16.3%-14.9%
Capital Expenditures i0N/A
Free Cash Flow i-15.46M-1.96B
FCF Margin i-8.1%-13.6%
Debt Repayment i-19.76M-6.31B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGUJINJECONESOURCE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i14.65M114.64M
Float Shares i1.00M70.43M
% Held by Insiders i63.90%38.63%
% Held by Institutions i0.00%26.67%
% Held by Public i36.10%34.70%

Dividend Analysis & Yield Comparison: Gujarat Inject (Kerala) Ltd. vs OneSource Specialty Pharma Inc.

MetricGUJINJECONESOURCE
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A